Cargando…
PCK2 inhibits lung adenocarcinoma tumor cell immune escape through oxidative stress-induced senescence as a potential therapeutic target
BACKGROUND: Our research aimed to better understand how phosphoenolpyruvate carboxykinase 2 (PCK2) is linked to survival outcomes in lung cancer patients. METHODS: We confirmed PCK2 expression and its association with the outcome of lung cancer patients using The Cancer Genome Atlas (TCGA) database....
Autores principales: | Tang, Mingming, Sun, Jianjun, Cai, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267946/ https://www.ncbi.nlm.nih.gov/pubmed/37324064 http://dx.doi.org/10.21037/jtd-23-542 |
Ejemplares similares
-
Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma
por: Zhao, Fen, et al.
Publicado: (2022) -
Escape from senescence: revisiting cancer therapeutic strategies
por: Zampetidis, Christos P., et al.
Publicado: (2022) -
Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma
por: Zang, Yiqing, et al.
Publicado: (2021) -
Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats
por: Kapoor, Sarika, et al.
Publicado: (2015) -
Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma
por: Liu, Meng-Xi, et al.
Publicado: (2018)